Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies. Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
NEEDHAM, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal...
Announced positive survival data from the phase 2 randomized controlled clinical trial of CAN-2409 in borderline resectable pancreatic cancerPresented positive topline overall survival data from...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.35 | 20.4545454545 | 6.6 | 7.96 | 6.5 | 306316 | 7.2237133 | CS |
4 | 2.77 | 53.4749034749 | 5.18 | 7.96 | 5.18 | 278249 | 6.56530592 | CS |
12 | 2.26 | 39.7188049209 | 5.69 | 7.96 | 4.9 | 302643 | 6.19230255 | CS |
26 | 6.55 | 467.857142857 | 1.4 | 14.33 | 1.3986 | 3021469 | 6.7884338 | CS |
52 | 6.74 | 557.024793388 | 1.21 | 14.33 | 0.66 | 1676439 | 6.24756749 | CS |
156 | 0.32 | 4.19397116645 | 7.63 | 14.33 | 0.66 | 580872 | 6.1792279 | CS |
260 | -0.05 | -0.625 | 8 | 14.78 | 0.66 | 562379 | 6.21754013 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.